SBI Misses the Mark? 🏦 | Biocon’s 7-Product Launch & The GLP-1 Boom!... 08-May-26

from GEPL Capital - Investment Talks - All About Investment, Nifty and Stock Ideas · host GEPL Capital Pvt. Ltd | SEBI Regd.: INZ000168137

A mixed bag on Dalal Street! SBI’s standalone profit hit ₹19,684 crore, but the stock faced pressure after missing analyst estimates. Join us as we break down the banking giant's Q4 scorecard and Biocon’s ambitious roadmap for North America. We discuss the potential of Biocon’s GLP-1 portfolio in FY27 and what the "Biosimilars" growth means for your healthcare holdings. Get the expert take here.

Episode metadata supplied by the publisher feed · Published May 8, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

SBI Misses the Mark? 🏦 | Biocon’s 7-Product Launch & The GLP-1 Boom!... 08-May-26

0:00 1:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GEPL Capital - Investment Talks - All About Investment, Nifty and Stock Ideas?

This episode is 1 minute long.

When was this GEPL Capital - Investment Talks - All About Investment, Nifty and Stock Ideas episode published?

This episode was published on May 8, 2026.

Can I download this GEPL Capital - Investment Talks - All About Investment, Nifty and Stock Ideas episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!